INTERVIEW | Biovac will not stop here, says CEO on new vaccine production deal

accreditation
Share your Subscriber Article
You have 5 articles to share every month. Send this story to a friend!
0:00
play article
Subscribers can listen to this article
Biovac CEO Dr Morena Makhoana expects that the deal with Pfizer will create about 100 additional jobs at its Pinelands plant.
Biovac CEO Dr Morena Makhoana expects that the deal with Pfizer will create about 100 additional jobs at its Pinelands plant.
Getty Images

Support independent journalism
Subscribe to News24 for just R75 per month to read all our investigative and in-depth journalism. You can cancel any time.
Subscribe
Already a subscriber? Sign in
Rand - Dollar
14.92
-1.1%
Rand - Pound
20.40
+0.2%
Rand - Euro
17.48
+0.3%
Rand - Aus dollar
10.83
+0.2%
Rand - Yen
0.13
+0.2%
Gold
1,750.56
0.0%
Silver
22.43
0.0%
Palladium
1,974.50
0.0%
Platinum
987.00
0.0%
Brent Crude
78.09
+1.1%
Top 40
57,643
0.0%
All Share
64,049
0.0%
Resource 10
57,254
0.0%
Industrial 25
82,879
0.0%
Financial 15
14,316
0.0%
All JSE data delayed by at least 15 minutes Iress logo
Company Snapshot
Voting Booth
What potential restrictions on unvaccinated South Africans may make the biggest difference to public health, the economy?
Please select an option Oops! Something went wrong, please try again later.
Results
Limited access to restaurants and bars
11% - 136 votes
Limited access to shopping centres
15% - 177 votes
Limited access to live events, including sport matches and festivals
26% - 319 votes
Workplace vaccine mandates
48% - 583 votes
Vote